Celldex Therapeutics (CLDX) Shares Issued (2010 - 2026)

Celldex Therapeutics' Shares Issued history runs 17 years deep, the most recent figure standing at $327000.0 for Q1 2026.

• In Q1 2026, Shares Issued rose 61.88% year-over-year to $327000.0; the TTM figure through Mar 2026 stood at $2.5 million (up 1156.5% YoY), while the FY2025 annual figure was $2.4 million, down 99.45% from the prior year.
• Shares Issued was $327000.0 for Q1 2026 at Celldex Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $432.3 million in Q1 2024 to a low of -$424.8 million in Q2 2024.
• Historically, Shares Issued has averaged $38.5 million across 5 years, with a median of $694000.0 in 2023.
• Biggest YoY gain for Shares Issued was 62191.07% in 2024; the steepest drop was 319478.95% in 2024.
• A 5-year view of Shares Issued shows it stood at $1.4 million in 2022, then soared by 15322.08% to $215.1 million in 2023, then surged by 96.87% to $423.5 million in 2024, then sank by 99.68% to $1.3 million in 2025, then tumbled by 75.76% to $327000.0 in 2026.
• The last three Shares Issued figures came in at $327000.0 (Q1 2026), $1.3 million (Q4 2025), and $774000.0 (Q3 2025), per Business Quant data.